Señales en vivo de CLNN | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 may 2024 @ 16:00):

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics...

Stats
Volumen de hoy	954 834
Volumen promedio	956 727
Capitalización de mercado	56.12M
EPS	$0 ( 2024-03-11 )
Próxima fecha de ganancias	( $-0.0900 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.930
ATR14	$0.00200 (0.46%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-24	General Resonance Llc	Sell	10 000	Common Stock
2024-04-09	General Resonance Llc	Sell	7 500	Common Stock
2024-04-09	General Resonance Llc	Sell	7 500	Common Stock
2024-04-09	General Resonance Llc	Sell	7 500	Common Stock
2024-03-11	Kiernan Matthew	Buy	29 481	Stock Options (Right to buy)

INSIDER POWER
99.19
Last 99 transactions
Buy: 46 168 962 \| Sell: 166 230

Volumen Correlación

Largo: -0.13 (neutral)

Corto: 0.98 (very strong)

Signal:(60.862) Expect same movement, but be aware

Clene Inc. Correlación

10 Correlaciones Más Positivas
ATNF	0.907
CMTL	0.906
ADN	0.906
MAGS	0.905
PROG	0.904
BEEM	0.901
CTMX	0.901
OPINL	0.901
INVZ	0.898
REFR	0.897

10 Correlaciones Más Negativas
TIOA	-0.905
LFST	-0.896
TIOAU	-0.895
SWAV	-0.889
BRIVU	-0.888
LEDS	-0.885
VLAT	-0.885
JAQC	-0.885
CREX	-0.882
BRIV	-0.88

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Clene Inc. Correlación - Moneda/Commodity

-0.73
( moderate negative )

-0.86
( strong negative )

0.00
( neutral )

0.30
( neutral )

Clene Inc. Finanzas

Annual	2023
Ingresos:	$654 000
Beneficio Bruto:	$-1.17M (-179.20 %)
EPS:	$-0.470

FY	2023
Ingresos:	$654 000
Beneficio Bruto:	$-1.17M (-179.20 %)
EPS:	$-0.470

FY	2022
Ingresos:	$473 000
Beneficio Bruto:	$447 000 (94.50 %)
EPS:	$-0.230

FY	2021
Ingresos:	$723 000
Beneficio Bruto:	$434 000 (60.03 %)
EPS:	$-0.160

Financial Reports:

No articles found.

Clene Inc.

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; ongoing Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a planned Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company's products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.